Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry

Successful short- and long-term relief of outflow tract obstruction was observed in experienced multidisciplinary HCM centers. A subset of patients progressed to develop HF, but event-free survival at 10 years was 83% and ventricular arrhythmias were rare. Older age, female sex, and SRT during childhood were associated with a greater risk of developing HF.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-10-02
DOI
https://doi.org/10.1161/circulationaha.124.069378
Citations
38
Primary Topic
Cardiomyopathy and Myosin Studies
Type
article
Field-Weighted Citation Impact
15.28

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry

Nosheen Reza, John C. Stendahl, Michelle Michels, Ioannis Skalidis et al.
38 citations
Circulation
Cardiomyopathy and Myosin Studies
15.28
article

Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry

Nosheen Reza, John C. Stendahl, Michelle Michels, Ioannis Skalidis, James S. Ware, Alejandro De Feria Alsina, Sara Saberi, Iacopo Olivotto, Joseph William Rossano, ANJALI TIKU OWENS, Rachel J. Lampert, Ashwin S. Nathan, Victoria Nicole Parikh, Matthew T. Wheeler, Kimberly Y. Lin, Niccolò Maurizi, Jodie Ingles, Dominic James Abrams, Adam S. Helms, Euan Angus Ashley, Sharlene M. Day, Thomas D. Ryan, Mark W. W. Russell, Carlo Fumagalli, Carolyn Ho, Brian Clagget, Panagiotis Anthiochos, Christopher Scemsarian, Neal Lakdwala
article en
38 citations

Abstract

Successful short- and long-term relief of outflow tract obstruction was observed in experienced multidisciplinary HCM centers. A subset of patients progressed to develop HF, but event-free survival at 10 years was 83% and ventricular arrhythmias were rare. Older age, female sex, and SRT during childhood were associated with a greater risk of developing HF.

CirculationVol. 150(17)
Brigham and Women's Hospital (US), Cincinnati Children's Hospital Medical Center (US), Boston Children's Hospital (US), The University of Sydney (AU), Children's Hospital of Philadelphia (US), Harvard University (US), Garvan Institute of Medical Research (AU), University of Michigan (US), Royal Prince Alfred Hospital (AU), Hospital of the University of Pennsylvania (US), Centenary Institute (AU), Erasmus MC (NL), Yale University (US), Lung Institute (US), Cancer Research And Biostatistics (US), Meyer Children's Hospital (IT), Michigan Medicine (US), Azienda Ospedaliero-Universitaria Careggi (IT), University of Campania "Luigi Vanvitelli" (IT), Cardiovascular Research Center (BR), University of Pennsylvania (US), Erasmus University Rotterdam (NL), University of Lausanne (CH)
American Heart Association, Bristol-Myers Squibb, Pfizer, Alexion Pharmaceuticals, Boston Scientific Corporation, Wellcome Trust, Cytokinetics, Amicus Therapeutics, National Institutes of Health, Medical Research Council, National Health and Medical Research Council, National Heart, Lung, and Blood Institute
Good health and well-being
Openalex Percentile: Top 1%
Cardiomyopathy and Myosin Studies
15.28
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.